Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of the Microenvironment and Immune System in Regulating Stem Cell Fate in Cancer
L. Paige Ferguson, Emily Diaz, Tannishtha Reya
Trends in cancer (2021) Vol. 7, Iss. 7, pp. 624-634
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Mechanism of Drug Tolerant Persister Cancer Cells: The Landscape and Clinical Implication for Therapy
Masashi Mikubo, Yoshiaki Inoue, Geoffrey Liu, et al.
Journal of Thoracic Oncology (2021) Vol. 16, Iss. 11, pp. 1798-1809
Open Access | Times Cited: 115
Integrated Machine Learning and Bioinformatic Analyses Constructed a Novel Stemness-Related Classifier to Predict Prognosis and Immunotherapy Responses for Hepatocellular Carcinoma Patients
Dongjie Chen, Jixing Liu, Longjun Zang, et al.
International Journal of Biological Sciences (2021) Vol. 18, Iss. 1, pp. 360-373
Open Access | Times Cited: 106
Arginase: An emerging and promising therapeutic target for cancer treatment
Fanglin Niu, Yi Yu, Zhuozhuo Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112840-112840
Open Access | Times Cited: 97
Prognosis and Dissection of Immunosuppressive Microenvironment in Breast Cancer Based on Fatty Acid Metabolism-Related Signature
Yuhui Tang, W. H. Tian, Jindong Xie, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 75
Single-cell sequencing of ascites fluid illustrates heterogeneity and therapy-induced evolution during gastric cancer peritoneal metastasis
Xuanzhang Huang, Min-Jiao Pang, Jiayi Li, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 50
Impact of Complex Apoptotic Signaling Pathways on Cancer Cell Sensitivity to Therapy
Ryungsa Kim, Takanori Kin, William T. Beck
Cancers (2024) Vol. 16, Iss. 5, pp. 984-984
Open Access | Times Cited: 21
Single-cell and spatial analyses revealed the co-location of cancer stem cells and SPP1+ macrophage in hypoxic region that determines the poor prognosis in hepatocellular carcinoma
Guangyu Fan, Tongji Xie, Lin Li, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 18
CD133+PD-L1+ cancer cells confer resistance to adoptively transferred engineered macrophage-based therapy in melanoma
Jiaojiao Xu, Zhe Li, Qinli Tong, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Cell plasticity, senescence, and quiescence in cancer stem cells: Biological and therapeutic implications
Ritama Paul, Jay F. Dorsey, Yi Fan
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107985-107985
Open Access | Times Cited: 103
Molecular Imaging of Cancer Stem Cells and Their Role in Therapy Resistance
Sofia Nascimento dos Santos, Timothy H. Witney
Journal of Nuclear Medicine (2025) Vol. 66, Iss. 1, pp. 14-19
Closed Access | Times Cited: 1
Unraveling the underlying mechanisms of cancer stem cells in therapeutic resistance for optimizing treatment strategies
Yunhan Tan, Siyuan Qin, Zhe Zhang, et al.
MedComm – Oncology (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 1
Cancer Stem Cells (CSCs), Circulating Tumor Cells (CTCs) and Their Interplay with Cancer Associated Fibroblasts (CAFs): A New World of Targets and Treatments
Beatrice Aramini, Valentina Masciale, Chiara Arienti, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2408-2408
Open Access | Times Cited: 33
Cancer Stem Cells and the Tumor Microenvironment: Targeting the Critical Crosstalk through Nanocarrier Systems
Aadya Nayak, Neerada Meenakshi Warrier, Praveen Kumar
Stem Cell Reviews and Reports (2022) Vol. 18, Iss. 7, pp. 2209-2233
Open Access | Times Cited: 30
Advancement in precision diagnosis and therapeutic for triple-negative breast cancer: Harnessing diagnostic potential of CRISPR-cas & engineered CAR T-cells mediated therapeutics
Vinayak Nayak, Sushmita Patra, Kshitij RB Singh, et al.
Environmental Research (2023) Vol. 235, pp. 116573-116573
Closed Access | Times Cited: 20
Tumour microenvironment changes after osimertinib treatment resistance in non-small cell lung cancer
Ruoshuang Han, Haoyue Guo, Jinpeng Shi, et al.
European Journal of Cancer (2023) Vol. 189, pp. 112919-112919
Open Access | Times Cited: 19
Breast Cancer Stem Cells: Signaling Pathways, Cellular Interactions, and Therapeutic Implications
Lei Wang, Jin Zeng, Rohan P. Master, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3287-3287
Open Access | Times Cited: 25
Understanding and Overcoming Immunosuppression Shaped by Cancer Stem Cells
Linheng Li, Roy A. Jensen
Cancer Research (2023) Vol. 83, Iss. 13, pp. 2096-2104
Open Access | Times Cited: 14
Immunological subtyping of salivary gland cancer identifies histological origin-specific tumor immune microenvironment
Jiyun Hong, Eunwoo Choi, Dahee Kim, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 5
Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer
Ruoshuang Han, Haoyue Guo, Jinpeng Shi, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Functional and clinical roles of stromal PDGF receptors in tumor biology
Carina Strell, Elisabet Rodríguez‐Tomàs, Arne Östman
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 4, pp. 1593-1609
Open Access | Times Cited: 5
Notch pathway regulates osimertinib drug‐tolerant persistence in EGFR‐mutated non–small‐cell lung cancer
Hirofumi Takahashi, Jun Sakakibara‐Konishi, Megumi Furuta, et al.
Cancer Science (2022) Vol. 114, Iss. 4, pp. 1635-1650
Open Access | Times Cited: 20
An immunogenic cell death-related signature predicts prognosis and immunotherapy response in stomach adenocarcinoma
Zitao Liu, Liang Sun, Xingyu Peng, et al.
APOPTOSIS (2023) Vol. 28, Iss. 11-12, pp. 1564-1583
Closed Access | Times Cited: 13
The role and participation of immune cells in the endometrial tumor microenvironment
Debasish Kumar Dey, Danielle Krause, Rajani Rai, et al.
Pharmacology & Therapeutics (2023) Vol. 251, pp. 108526-108526
Closed Access | Times Cited: 13
Unravelling the CXCL12/CXCR4 Axis in breast cancer: Insights into metastasis, microenvironment interactions, and therapeutic opportunities
Priyanka Garg, Venkateswara Rao Jallepalli, Sonali Verma
Human Gene (2024) Vol. 40, pp. 201272-201272
Closed Access | Times Cited: 4
Discrete Mechanistic Target of Rapamycin Signaling Pathways, Stem Cells, and Therapeutic Targets
Meena Jhanwar‐Uniyal, Sabrina L. Zeller, Eris Spirollari, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 409-409
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top